Ignite Creation Date:
2025-12-24 @ 9:29 PM
Ignite Modification Date:
2025-12-25 @ 7:14 PM
Study NCT ID:
NCT06140732
Status:
RECRUITING
Last Update Posted:
2023-11-20
First Post:
2023-11-08
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Apatinib Combined With Camrelizumab in Treating Participants With Advanced Chordoma
Sponsor:
Xuanwu Hospital, Beijing
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-30
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-01-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-08
First Submit QC Date:
None
Study First Post Date:
2023-11-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-14
Last Update Post Date:
2023-11-20
Last Update Post Date Type:
ACTUAL